TruthArchive.ai - Related Video Feed

Scientists are investigating claims that COVID-19 was manipulated in a lab after a tiny DNA fragment matching a sequence patented by Moderna was found in the virus. The possibility of an accidental lab escape is being considered, as human error is always a factor. The Wuhan lab in China may have been conducting research on virus enhancement or gene modification, leading to an infection that spread to others. The scientists are currently analyzing the data to determine the validity of these claims. It will take time to thoroughly examine the genetic evidence.

We need to be proactive in searching for emerging diseases before they become a global threat. Peter Daszak, who collaborated with the Wuhan Institute of Virology, discovered 50 previously unknown Coronaviruses in bats. These Coronaviruses have the potential to jump from wildlife to humans. Our organization works with labs worldwide, subcontracting the work and ensuring we have a country program officer in each location to manage our projects.

Many viruses use a 2-step authentication process to enter cells, involving binding to a receptor and spike protein cleavage. Virologists have been adding furin cleavage sites to viruses since 1992, increasing their virulence. SARS-CoV-2, which likely originated from nature, contains unique furin cleavage site codons not typical in coronaviruses. This suggests a low probability of natural origin.

In 1965, coronavirus was identified as a pathogen that could be modified for various purposes. The first human manipulation experiment took place in 1966, followed by transatlantic data sharing in 1967. In the 1970s, coronavirus was modified in animals like pigs and dogs. By 1990, it was discovered that coronavirus caused gastrointestinal issues in dogs and pigs, leading to Pfizer filing the first spike protein vaccine patent. The spike protein was not a new problem, as it was known since 1990. Vaccines for coronavirus have been ineffective due to its ability to mutate quickly, as stated in numerous independent scientific publications. In 2002, the University of North Carolina Chapel Hill patented an infectious replication defective clone of coronavirus, funded by Anthony Fauci. This suggests that SARS was engineered and not a naturally occurring phenomenon.

We isolated coronaviruses from animals in the past to understand their threat to other species by culturing them on different cell types. This process, known as gain of function, involves enriching mutants that can infect new species. The speaker emphasizes that mass vaccination in humans is a significant gain of function experiment, leading to virus evolution. This real-world experiment involves constant virus changes due to human-to-human transmission under vaccine pressure.

Concerning research from China was published last week. Researchers took a virus from pangolins and cultured it in a lab. They then infected mice with this virus, which killed all of them through brain infection. These mice were transgenic, meaning they had human ACE receptor genes. The virus, a coronavirus from pangolins, killed all the infected mice. This kind of experimentation is dangerous and should be banned immediately.

In 1965, coronavirus was identified as a pathogen that could be modified for various purposes. The first transatlantic coronavirus experiment took place in 1966, followed by human trials in 1967. In the 1970s, coronavirus was manipulated in animals, and by 1990, it was recognized as a problem for dogs and pigs. Pfizer filed the first spike protein vaccine patent in 1990. It was known since then that coronavirus mutates too quickly for vaccines to be effective. In 2002, the University of North Carolina Chapel Hill patented an infectious replication defective clone of coronavirus, funded by Anthony Fauci. SARS 1.0 was engineered and not a naturally occurring phenomenon.

Animal viruses that jump to humans often struggle to infect effectively due to their evolution in animals. The first SARS virus in 2003 had a 10% mortality rate but only infected 8,000 people because it didn't adapt well to humans. In contrast, COVID-19 attached perfectly to humans, suggesting possible lab manipulation. Researchers used a supercomputer to find that the virus did not attach well to other animals, indicating it was pre-adapted for humans. Evidence points to a 2018 research project that aimed to create a virus similar to COVID-19. Despite this, obtaining records from the Biden administration has been challenging, even with bipartisan support for transparency. The situation remains frustrating, highlighting the need for further investigation.

Scientists analyzed the genetic code of viruses to trace their origins. By studying the molecular clock, they found that SARS-CoV-2 had no posterior diversity, indicating a single source in Wuhan. Research showed hospitals in Wuhan were clustered along a subway line connecting the Wuhan Institute of Virology, the wet market, and the international airport, suggesting a potential route of transmission. The speaker collaborated with the State Department in 2020 to investigate these findings.

The speaker discusses the global wildlife trade and its connection to the emergence of new diseases. They focus on SARS and how it originated from a wildlife market. Through surveillance of bats in Southern China, they have discovered over 100 new SARS-related coronaviruses that pose a threat to humans. Some of these coronaviruses can infect human cells and cause SARS-like disease. The speaker emphasizes the need for continued surveillance and understanding of these spillover events, as any one of them could potentially lead to a pandemic. They also mention the challenges in developing vaccines and antivirals for these diverse coronaviruses.

Coronavirus was isolated in 1965 and quickly identified as a pathogen for experimentation. In 1966, the first COV model was used in human manipulation experiments. By 1990, Pfizer patented a spike protein vaccine for coronavirus. Research showed vaccines were ineffective due to the virus mutating rapidly. In 2002, the University of North Carolina patented an infectious replication defective clone of coronavirus, funded by Anthony Fauci. This work preceded SARS 1.0 by a year, suggesting engineered origins.

The coronavirus spike protein's shape before interacting with our cells is key to triggering an antibody response. To study this, we create the spike protein in the lab, maintaining its precise shape. This is achieved using a "clamp"—a small fragment of HIV protein—that holds the spike protein in its natural, pre-interaction conformation. This ensures the lab-made protein accurately reflects the virus's structure, allowing for effective antibody response studies.

We created coronaviruses by assembling a synthetic bat genome with the SARS clone. The genome was split into 5 kilobyte pieces with unique restriction sites to allow directional assembly. Initially, the virus couldn't replicate due to an entry defect, so we replaced the receptor binding domain with one from the human epidemic strain. This modification resulted in a virus that replicated efficiently. The growth curve data supported this success.

The leaked DEFUSE proposal from the Wuhan Institute of Virology and their American partners reveals their risky research on the parts of COVID-19 that make it highly infectious to humans. Scientists believe this proposal provides a step-by-step guide to creating SARS-CoV-2, the virus responsible for COVID-19. The proposal's specificity in constructing a virus with all the key hallmarks of SARS-CoV-2 is seen as more than just a coincidence. Researchers, including Shizeng Li and Ben Hu, who is considered a potential patient zero, were involved in this research. Hu's work on genetically engineering coronaviruses from bats and his early COVID-like symptoms further support the possibility of him being patient zero.

Chinese researchers have created a super virus by combining a protein from bats with the SARS virus found in mice. This virus could potentially infect humans, although it is currently only being studied in laboratories. The debate over the risks of this research is not new, with some scientists arguing that the benefits outweigh the potential dangers. However, others are concerned about the possibility of the virus directly infecting humans without an intermediate species. The US government had previously suspended funding for research aiming to make viruses more contagious, but this did not stop the Chinese research on SARS. Some experts believe the chances of the virus spreading to humans are minimal compared to the potential benefits, while others disagree.

Scientists sequence the virus and compare it to known pathogens like SARS. They discovered similar coronaviruses in bats and focused on the spike protein that attaches to cells. Chinese researchers created pseudoparticles with spike proteins from these viruses to test their binding to human cells. Each step of this process helps determine if the virus can become pathogenic in humans. Manipulating the spike protein in the lab is crucial for understanding the zoonotic risk. By obtaining the sequence, scientists can predict the virus's behavior more accurately.

Scientists are investigating the possibility of the COVID-19 virus originating from a lab in Wuhan. They are analyzing data to determine the accuracy of claims that the virus matches a genetic sequence patented by Moderna for cancer research. The hypothesis of a lab escape is being considered, as human error is possible. It is speculated that the Wuhan lab may have been working on virus enhancement or gene modification, leading to an accidental infection. The analysis of genetic sequences is a time-consuming process, but the scientists are diligently examining the evidence. The work being done by the scientists is crucial in understanding the origins of the virus.

In 2015, the National Library of Medicine published a study by 15 virologists and medical experts warning that SARS-like bat coronaviruses pose a potential threat to humans. The scientists, with decades of experience in studying coronaviruses, examined how SARS and MERS transmitted among humans. They modified a strain of coronavirus from Chinese horseshoe bats using gain of function technology and injected it into mice spinal cords. This study not only highlights the dangers of coronaviruses in bats but also demonstrates efforts to amplify the virus's contagion ability to better understand and prepare for future outbreaks.

The spike protein of the coronavirus plays a crucial role in triggering a strong antibody response. To study it in the lab, Keith uses a small fragment of HIV as a clamp to lock the spike protein into its original shape. This helps maintain the structure of the virus on its surface.

Evolutionary virologists analyzed viral sequences from the current outbreak and in bats. They determined that the mutations required for the virus to jump from an animal to a human are entirely consistent with its evolutionary path. A paper detailing this research will be made available, although the authors are not currently named.

In South America and Southeast Asia, there are many bat species carrying unknown viruses, making them potential sources of future pandemics. The USAID EPT predict program and NIAID funding allowed researchers to predict and prepare for emergencies like the SARS outbreak. They discovered that SARS-like viruses originate from bats in China, with some being almost identical to SARS. Surveillance of bat hunters and nearby residents revealed the potential for spillover into human populations. While there are no vaccines or antivirals for these diverse coronaviruses, scientists can manipulate them in the lab by studying their spike proteins. This knowledge can aid in the development of better vaccines and therapeutics. However, predicting and anticipating pandemics does not guarantee prevention.

The speaker explains that the spike protein on the coronavirus is crucial for its structure and interaction with our cells. To trigger a protective antibody response, Keith replicates the spike protein in the lab and locks it into the same shape using a clamp-like protein. Surprisingly, this clamp-like protein is a small fragment of HIV.

There are ongoing research programs worldwide, including in China, to develop vaccines for coronaviruses. These programs aim to modify existing vaccines or create new ones to combat viruses that have previously jumped from animals to humans. The focus is on understanding how these viruses can be altered or adapted to effectively protect against them.

In the lab, it's easy to manipulate spike proteins, which play a significant role in the zoonotic risk of coronaviruses. By obtaining the sequence and constructing the protein, we collaborated with Ralph Barrick at UNC to insert it into another virus. This allows us to conduct experiments and enhance our ability to predict outcomes based on specific sequences.

We focus on viral families that have transmitted from animals to humans. When we find a virus that resembles a known dangerous pathogen, like SARS, we examine its spike protein, which attaches to cells. Chinese researchers create pseudo particles with these spike proteins to test if they bind to human cells. This process helps us identify viruses that could potentially be harmful to humans. By narrowing down the field and reducing costs, we end up with a small number of viruses that appear to be dangerous. We then investigate if people living in the same region as the animals carrying these viruses have developed antibodies.